Research labelling Research-use labelling should avoid medical-use wording and clearly separate research context from human-use claims
How Will Medicare and Medicaid Coverage Evolve for GLP-1 Drugs in 2025-2026
She also sees potential for the practice to help treat less severe cases: Depending on the dosage, [GLP-1 agonists] can help with weight loss or even just on fullness, food noise, or inflammation. Patients interested in microdosing should speak with their health care provider to determine whether it might be an option, which medications they should take, and precisely how to adjust and take their doses
No matter the reason (and maybe you just arent interested in taking a medication forever), developing sound nutrition and lifestyle habits will set you up for the best GLP-1 success while on your medication and in the future should you decide not to take it at any point
10.1038/s41573-018-0008-x 43 CummingsJ
Dieting is a marathon, not a sprint